Full-Time

Sales Representative

Foot & Ankle

Stryker

Stryker

10,001+ employees

Develops and manufactures medical devices and equipment

No salary listed

Solihull, UK + 4 more

More locations: Derby, UK | Leicester, UK | Birmingham, UK | Coventry, UK

In Person

Category
🤝Sales & Account Management (1)
Required Skills
Sales
Requirements
  • Excellent communication and presentation skills, adept in building relationships
  • Successful sales experience or clinical experience and a strong sales drive
  • Good working knowledge of anatomy and physiology
  • Experience in team working must be demonstrated
  • Workshop/demonstration skills/training skills
  • A full, valid UK drivers license
Responsibilities
  • Responsible for meeting and exceeding sales objectives for accounts within defined territory geography alongside three other team members
  • Represent Stryker as a leader in our industry and the marketplace by building and maintaining strong business relationships with key surgeons and HCP’s
  • Capable of managing a high-volume activity, drive market growth in line with expectations and implement cross divisional strategy to capture new business growth

Stryker develops and manufactures medical devices and equipment aimed at improving patient care and surgical efficiency. Their products include surgical tools, neurotechnology devices, and orthopedic implants, which are sold directly to hospitals and clinics worldwide. Stryker stands out from its competitors by focusing on high-quality products and a commitment to advancing healthcare solutions. The company's goal is to enhance the overall healthcare experience for both patients and medical professionals.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for minimally invasive solutions aligns with Stryker's strategic acquisitions.
  • The orthopedic implants market growth benefits Stryker's expanding product line.
  • Stryker's acquisition of Inari Medical positions it in a high-growth vascular market.

What critics are saying

  • Integration challenges from acquisitions may strain Stryker's resources.
  • Rapid tech advancements risk obsolescence of Stryker's current products.
  • Regulatory scrutiny on acquisitions could delay Stryker's market entry.

What makes Stryker unique

  • Stryker's acquisitions enhance its minimally invasive surgical solutions portfolio.
  • Entry into the peripheral vascular segment diversifies Stryker's market presence.
  • Stryker's focus on AI integration boosts diagnostic accuracy and operational efficiency.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical & prescription plans

Supplemental health benefits

Flexible Spending accounts

Employee Assistance Program

Short-term & long-term disability

Tuition reimbursement

401(k) plan

Employee Stock Purchase Plan

Company News

GlobeNewswire
Jan 6th, 2025
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment

Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) --  Stryker (NYSE: SYK), a global leader in medical technologies, announced...

PR Newswire
Sep 20th, 2024
Stryker completes acquisition of NICO Corporation, expanding minimally invasive solutions for brain tumor removal and stroke care

/PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of NICO Corporation, a...

Surgical Robotics Technology
Aug 22nd, 2024
Stryker Announces Definitive Agreement to Acquire Vertos Medical Inc.

Stryker has announced a definitive agreement to acquire Vertos Medical, a privately held company providing a minimally invasive solution.

Surgical Robotics Technology
Aug 12th, 2024
Stryker Announces Definitive Agreement to Acquire care.ai

Stryker has announced a definitive agreement to acquire care.ai.

PR Newswire
Jul 31st, 2024
Stryker Acquires MOLLI Surgical Inc.

Stryker (NYSE:SYK) has completed the acquisition of MOLLI Surgical Inc., a company specializing in wire-free soft tissue localization technology for breast conserving surgery. The MOLLI 2 localization system enhances surgical workflow with its small 3.2 mm marker and real-time feedback. This acquisition strengthens Stryker's breast cancer care portfolio, complementing its existing SPY fluorescence imaging technology. For more information, visit www.stryker.com.